🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
Grand Hôpital de Charleroi (GHdC) had to organize the vaccination of its st...
Status
Completed
Location
Grand Hôpital de Charleroi
Start Date
2021-02-05
Trial ID
NCT04813497
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
Prospective, non-equality, cohort study, where investigators propose to ana...
Status
Completed
Location
Virgen del Rocio University Hospital
Start Date
2021-04-01
Trial ID
NCT05633927
Treatments Being Tested
This is an open-label, prospective observational study in people 18 years o...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2024-09-19
Trial ID
NCT06667063
Although immune checkpoint inhibitors (ICIs) have substantially extended su...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07597070
Treatments Being Tested
The aim of the clinical study is to study the safety, reactogenicity and im...
Status
Completed
Location
Federal State Budgetary Institution of Healthcare "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency" (FGBUZ MSCH-163, FMBA of Russia)
Start Date
2020-11-19
Trial ID
NCT05021016
Treatments Being Tested
This is a randomised controlled, adaptive, multicentre Phase II protocol ev...
Status
Completed
Location
University Hospital Cologne
Start Date
2021-11-08
Trial ID
NCT05160766
Treatments Being Tested